2020 GeneSystems Watch List

Description Developer of commercial blood tests for the early detection of cancers. The company'... More Description
Developer of commercial blood tests for the early detection of cancers. The company's proprietary diagnostics tests focus on identification, validation and commercialization of novel protein biomarkers useful for early detection of lung cancer and for guiding the selection and administration of therapy, enabling physicians to improve outcomes of people at high risk for specific types of cancers.

Website: www.2020gene.com
Business Status: Generating Revenue
Ownership Status: Privately Held (backing)
Financing Status: Venture Capital-Backed
Year Founded: 2000
Employees: 16

Primary Contact
Jonathan Cohen
Founder, Chief Executive Officer & President
jcohen@2020gene.com
Phone: +1 (240) 453-6339

Primary Office
9430 Key West Avenue
Suite 100
Rockville, MD 20850
United States
investors@2020gene.com
Phone: +1 (240) 453-6339
Fax: +1 (240) 403-0289

Less

Please evaluate the company’s performance

Click to rate this post!
[Total: 2 Your Rating: 5]